RIPK4 was required for the survival of human diffuse large B-cell lymphoma (DLBCL) cells primarily through controlling NF-κB activation induced by the B cell-activating factor of the tumor necrosis factor family (BAFF). The gene discussed is RIPK4; the disease is diffuse large B-cell lymphoma.